386

Compound name
Pazopanib
Alt Name
Votrient
Compound Image
Pazopanib.png
SMILES
CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl
Brutto
C21H24ClN7O2S
InChI
InChI=1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H
InChI Key
MQHIQUBXFFAOMK-UHFFFAOYSA-N
Approval Jurisdiction
2009 FDA, 2010 EMA, MHRA, TGA
Approved for clinical use
Renal Cancer
CAS
635702-64-6
PubChem CID
11525740
Action
VEGFR2, PDGFR, c-KIT
Approved Drug List
1
Commercial Vendor
GSK